NCT01004016View on ClinicalTrials.gov

A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

Not specified

Conditions
Spinocerebellar Degeneration
Interventions
DRUG

KPS-0373

DRUG

Placebo

Trial Locations (1)

Unknown

Japan, Japan

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT01004016 - A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) | Biotech Hunter | Biotech Hunter